Topco Scientific is hard to go wrong with, thanks to really competent management and how far it has come in the past five or six years on the back of semiconductor supply chain shifts. Per @Blinklebloop, it is Shin-Etsu's primary agent for silicon wafers and photoresists in Taiwan and parts of China, looks relatively cheap at about 15 times earnings for its supply chain position, and management expects double-digit revenue growth this year. x.com 

Cadence's IBD composite and EPS ratings of 90 support its standing as arguably the best in the 'making chips better' group after ASML. The screen estimates 2026 EPS growth of 18% and sales growth of 21%. Its chart is near a breakout after a long pullback. x.com 

Lam Research's non-China demand growth and steady earnings estimates make its lower multiple a rebound setup if its guide holds. China's revenue share fell from 43% to 26% as Taiwan and Korea grew, while the fiscal 2027 earnings multiple fell from about 37x to 28x on nearly unchanged estimates. An in-line quarter and December guide near consensus would probably lift the stock; a guide below $8.5bn would back the selloff. x.com 

Low multiples give AI infrastructure good risk/reward as demand outruns supply and agentic workloads have runway. TSMC at 17x 2027E EPS appears to have all the accelerator and CPU demand it can handle this year and next; Ultra Clean is at 8x, MKS 12x, TTM 13x, Nvidia 14x and Celestica 15x. Kioxia at 3x and Samsung preferreds at 2.5x carry a big discount on pricing and cycle fears. Multiples imply a 2027 capex peak and meaningful drop; 2028 capex growth is expected, but below 2027's rate. x.com  … Show more

Lam Research's record results suggest the equipment cycle is not ending despite its stock selloff. Revenue reached $8.22B, up 54% year over year and over 20% sequentially, while EPS rose 75%; ASML and TSMC also report customers needing more tools. Overweight with a $355 target and 35% upside, but the selloff is a gift only if Lam guides December higher. x.com  x.com 

Shin-Etsu Chemical is shifting from a chemical conglomerate to a chip-supply bottleneck, owning lithography and chemistry patents essential to the glass-substrate era. In 1,000W+ AI data centers glass is already required, as organic substrates warp and crack under the heat of Nvidia's Rubin systems. Intel and Samsung have moved pilot lines into volume production, with Shin-Etsu supplying bonding chemistry and masks. Cyclical PVC cash funds its electronics push, supporting a re-rating. x.com  … Show more

Taiwan equities bundle real AI chokepoints with pricing power and no near-term substitutes for about 21x forward earnings, versus about 30x for US semiconductors. TSMC holds about 90% of sub-7nm manufacturing and is raising CoWoS prices; Unimicron and Elite Material control ABF substrates and CCL; ASE runs advanced packaging above 90% utilization; Delta supplies power and cooling for 120-230kW racks at 30-40% lower cost than Western rivals. Taiwan also offers lower beta and volatility. x.com  … Show more

Semiconductor stocks have not priced in a record wave of AI chip demand. Taiwan chip exports jumped over 20% in a single month and demand is 30% above three months earlier, the biggest in history, while Korea is also seeing record semiconductor demand, up 30% on mid-2026. A step change in demand comes while semis are still cheaper than before the AI boom. x.com  x.com  x.com  x.com 

TSMC belongs in every portfolio because its growth, moat, market dominance and pricing power are unmatched, and ignoring it over China risk is a mistake. It holds about 90% of the advanced-node market, and the AI buildout keeps pulling demand toward the chips it makes best. Even assuming growth slows to 14%, gross margin eases to 63.5% and a 25x exit multiple, the stock reaches $937 by 2031, a 17.75% annual return. Risks include China, rising capex, customer concentration and hyperscaler cuts. … Show more

ACM Research should benefit as China's wafer fab equipment spending soars over the next couple of years across memory and leading-edge logic, more than offsetting lower mature-node spending. Its advanced packaging sales to non-Chinese clients are also growing well, and valuation looks reasonable after the recent pullback. x.com